Rev Neurol. 2013 Jul 16;57(2):57-63.
[Vagus nerve stimulation in patients with migraine].
[Article in Spanish]
Mosqueira AJ, Lopez-Manzanares L, Canneti B, Barroso A, Garcia-Navarrete E, Valdivia A, Vivancos J.
Source
Hospital Universitario de la Princesa, 28006 Madrid, Espana.
Abstract
in English
INTRODUCTION. Vagus nerve stimulation (VNS) has been approved for the treatment of refractory epilepsy when resective surgery is not possible, and has proved to be highly effective. Series published in the literature suggest a beneficial effect of VNS in the treatment of migraine. AIMS. To determine the degree to which headaches improve in patients with migraine after the placement of VNS to treat refractory epilepsy, and to evaluate what variables are associated with an increased chance of success with this measure. PATIENTS AND METHODS. An observation-based retrospective study was conducted from 1st January 1999 until 31st December 2010. Patients with VNS for refractory epilepsy were contacted by telephone, after selecting those who fulfilled International Headache Society criteria for migraine. Data collected included age, gender, year of placement, age at onset of epilepsy and migraine, improvement of seizures and migraine, presence of migraine with aura and coexistence of anxious-depressive syndrome. Ninety-four patients with VNS were contacted and 13 patients with migraine were selected. RESULTS. Following placement of the VNS, the number of episodes of migraine was seen to decrease by at least 50% in nine patients (69%) (p = 0.004) and there was a drop in the number of episodes of migraine in those patients who had also reduced their epileptic seizures (p = 0.012). No statistically significant associations were observed as regards sex, age, length of disease history, existence of migraine with aura or coexistence of anxious-depressive syndrome. CONCLUSIONS. VNS could have beneficial effects for patients with migraine, especially in cases that are difficult to control. Due to the type of study, these conclusions must be taken with caution. Prospective clinical studies are needed before introducing the technique into daily clinical practice.
- PMID:
- 23836335
- [PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/23836335
Related citations in PubMed
- Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.[Epilepsy Behav. 2010]
Cumulative effect of vagus nerve stimulators on intractable seizures observed over a period of 3years.
Siddiqui F, Herial NA, Ali II. Epilepsy Behav. 2010 Jul; 18(3):299-302. Epub 2010 May 23.
- Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches.[Cephalalgia. 2005]
Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches.
Mauskop A. Cephalalgia. 2005 Feb; 25(2):82-6.
- Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy.[Neurology. 2002]
Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy.
Renfroe JB, Wheless JW. Neurology. 2002 Sep 24; 59(6 Suppl 4):S26-30.
- Review Vagus nerve stimulation: indications and limitations.[Acta Neurochir Suppl. 2007]
Review Vagus nerve stimulation: indications and limitations.
Ansari S, Chaudhri K, Al Moutaery KA. Acta Neurochir Suppl. 2007; 97(Pt 2):281-6.
- Review Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response.[J Neurosurg. 2011]
Review Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response.
Englot DJ, Chang EF, Auguste KI. J Neurosurg. 2011 Dec; 115(6):1248-55. Epub 2011 Aug 12.
